# Cancer Research Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/cancer-research-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 92.8 |
| Citations | 4,491,408 |
| City | Columbia |
| Country | US |
| Description | Cancer Research Center is a research organisation in Columbia, US. OpenAlex records 19,028 works and 4,491,408 citations for it. 3,642 researchers list it as their most recent affiliation. |
| Homepage | http://www.cancerresearchcenter.org/ |
| OpenAlex ID | https://openalex.org/I4210127473 |
| Researchers | 3,642 |
| ROR ID | https://ror.org/03fbwjm33 |
| Type | nonprofit |
| Works | 19,028 |

## University papers

Showing 12 of 77.

- [Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer](https://scholariq.org/papers/anaplastic-lymphoma-kinase-inhibition-in-non-small-cell-lung-cancer/)
- [<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling](https://scholariq.org/papers/i-met-i-amplification-leads-to-gefitinib-resistance-in-lung-cancer-by-activating/)
- [Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors](https://scholariq.org/papers/genotypic-and-histological-evolution-of-lung-cancers-acquiring-resistance-to/)
- [The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism](https://scholariq.org/papers/the-evolution-of-phosphatidylinositol-3-kinases-as-regulators-of-growth-and/)
- [Systematic identification of genomic markers of drug sensitivity in cancer cells](https://scholariq.org/papers/systematic-identification-of-genomic-markers-of-drug-sensitivity-in-cancer-cells/)
- [Targeting PI3K signalling in cancer: opportunities, challenges and limitations](https://scholariq.org/papers/targeting-pi3k-signalling-in-cancer-opportunities-challenges-and-limitations/)
- [Interleukin-1 polymorphisms associated with increased risk of gastric cancer](https://scholariq.org/papers/interleukin-1-polymorphisms-associated-with-increased-risk-of-gastric-cancer/)
- [Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway](https://scholariq.org/papers/dependency-of-a-therapy-resistant-state-of-cancer-cells-on-a-lipid-peroxidase/)
- [Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/breast-cancer-version-3-2020-nccn-clinical-practice-guidelines-in-oncology/)
- [Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints](https://scholariq.org/papers/adaptive-resistance-to-therapeutic-pd-1-blockade-is-associated-with-upregulation/)
- [<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers](https://scholariq.org/papers/i-ros1-i-rearrangements-define-a-unique-molecular-class-of-lung-cancers/)
- [Ceritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer](https://scholariq.org/papers/ceritinib-in-i-alk-i-rearranged-non-small-cell-lung-cancer/)

## University researchers

- [Jeffrey A. Engelman](https://scholariq.org/researchers/jeffrey-a-engelman/)
- [Howard A. Young](https://scholariq.org/researchers/howard-a-young/)

## University top topics

Showing 8 of 25.

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.